Please login to the form below

Not currently logged in
Email:
Password:

GSK's Rotarix vaccine resumes use in US

The US Food and Drug Administration has recommended that inoculations with GSK's Rotarix resume, following concerns over contamination

The US Food and Drug Administration (FDA) has recommended that inoculations with GlaxoSmithKline(GSK)'s Rotarix resume, having given it the all-clear following concerns over contamination. The vaccine is designed to protect babies against rotavirus, a leading cause of severe diarrhoea – a major cause of death in developing countries.

The announcement follows an almost two-month pause in the rotavirus vaccine's use owing to the presence of porcine circovirus-1 (PCV-1) contamination.

In March, the FDA urged paediatricians to temporarily stop using the rotavirus vaccine after discovering that doses of it were contaminated with bits of an apparently benign pig virus. They suggested doctors use Merck's RotaTeq vaccine instead. 

On Friday (May 14, 2010), the agency reversed its decision, saying there is no evidence that porcine circovirus can infect or sicken humans.

In March, the European Medicines Agency (EMA) had also suggested that paediatricians should not use Rotarix, but it reversed this recommendation a few days later.

Merck's vaccine was introduced in 2006 and GSK's in 2008. GSK's oral vaccine has been used in millions of children worldwide, including one million in the US, with no signs of safety problems, health officials said.

17th May 2010

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Women in science
The role of women in science and technology
Why the lack of female leaders in pharma and life sciences is a problem that still needs to be fixed...
Maria Dahl
China’s homecoming heroes fuel a biotech boom with rapid CAR-T advances
China secures a place at the forefront of innovative medicine...
Virtual Research Grants Submission and Approval Program
Impetus Digital summarizes how a client established an independent grant review committee and a virtual grant submission and approval program, without having to travel and meet in person....

Infographics